Industry: Chemical & Material
Published Date: 2024-09-25
Pages: 137 Pages
Report ld: 3329790
Request Sample
Customized Report
Erythromycin Thiocyanate API Market Size(US$)

CAGR 2024-2030
5.5%
Market Size,2030
USD 2,274
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2274 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
The US & Canada market for Erythromycin Thiocyanate API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Erythromycin Thiocyanate API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Erythromycin Thiocyanate API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Erythromycin Thiocyanate API include Yili Chuannig Biotechnology, Yichang East Sunshine, Alebi Pharma, META Pharmaceuticals, Anuh Pharma, HEC Group, AbbVie, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Erythromycin Thiocyanate API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Erythromycin Thiocyanate API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for Erythromycin Thiocyanate API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Erythromycin Thiocyanate API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Erythromycin Thiocyanate API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Erythromycin Thiocyanate API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Erythromycin Thiocyanate API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Erythromycin Thiocyanate API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Yili Chuannig Biotechnology, Yichang East Sunshine, Alebi Pharma, META Pharmaceuticals, Anuh Pharma, HEC Group, AbbVie, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Erythromycin Thiocyanate API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Erythromycin Thiocyanate API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Erythromycin Thiocyanate API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erythromycin Thiocyanate API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Erythromycin Thiocyanate API Product Introduction
1.2 Market by Type
1.2.1 Global Erythromycin Thiocyanate API Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Industrial Grade
1.2.3 Feed Grade
1.2.4 Pharmaceutical Grade
1.3 Market by Application
1.3.1 Global Erythromycin Thiocyanate API Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Erythromycin Synthesis
1.3.3 Feed Additive
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Erythromycin Thiocyanate API Production
2.1 Global Erythromycin Thiocyanate API Production Capacity (2019-2030)
2.2 Global Erythromycin Thiocyanate API Production by Region: 2019 VS 2023 VS 2030
2.3 Global Erythromycin Thiocyanate API Production by Region
2.3.1 Global Erythromycin Thiocyanate API Historic Production by Region (2019-2024)
2.3.2 Global Erythromycin Thiocyanate API Forecasted Production by Region (2025-2030)
2.3.3 Global Erythromycin Thiocyanate API Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Erythromycin Thiocyanate API Revenue Estimates and Forecasts 2019-2030
3.2 Global Erythromycin Thiocyanate API Revenue by Region
3.2.1 Global Erythromycin Thiocyanate API Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Erythromycin Thiocyanate API Revenue by Region (2019-2024)
3.2.3 Global Erythromycin Thiocyanate API Revenue by Region (2025-2030)
3.2.4 Global Erythromycin Thiocyanate API Revenue Market Share by Region (2019-2030)
3.3 Global Erythromycin Thiocyanate API Sales Estimates and Forecasts 2019-2030
3.4 Global Erythromycin Thiocyanate API Sales by Region
3.4.1 Global Erythromycin Thiocyanate API Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Erythromycin Thiocyanate API Sales by Region (2019-2024)
3.4.3 Global Erythromycin Thiocyanate API Sales by Region (2025-2030)
3.4.4 Global Erythromycin Thiocyanate API Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Erythromycin Thiocyanate API Sales by Manufacturers
4.1.1 Global Erythromycin Thiocyanate API Sales by Manufacturers (2019-2024)
4.1.2 Global Erythromycin Thiocyanate API Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erythromycin Thiocyanate API in 2023
4.2 Global Erythromycin Thiocyanate API Revenue by Manufacturers
4.2.1 Global Erythromycin Thiocyanate API Revenue by Manufacturers (2019-2024)
4.2.2 Global Erythromycin Thiocyanate API Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Erythromycin Thiocyanate API Revenue in 2023
4.3 Global Erythromycin Thiocyanate API Sales Price by Manufacturers (2019-2024)
4.4 Global Key Players of Erythromycin Thiocyanate API, Industry Ranking, 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Erythromycin Thiocyanate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Erythromycin Thiocyanate API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Erythromycin Thiocyanate API, Product Offered and Application
4.8 Global Key Manufacturers of Erythromycin Thiocyanate API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Erythromycin Thiocyanate API Sales by Type
5.1.1 Global Erythromycin Thiocyanate API Historical Sales by Type (2019-2024)
5.1.2 Global Erythromycin Thiocyanate API Forecasted Sales by Type (2025-2030)
5.1.3 Global Erythromycin Thiocyanate API Sales Market Share by Type (2019-2030)
5.2 Global Erythromycin Thiocyanate API Revenue by Type
5.2.1 Global Erythromycin Thiocyanate API Historical Revenue by Type (2019-2024)
5.2.2 Global Erythromycin Thiocyanate API Forecasted Revenue by Type (2025-2030)
5.2.3 Global Erythromycin Thiocyanate API Revenue Market Share by Type (2019-2030)
5.3 Global Erythromycin Thiocyanate API Price by Type
5.3.1 Global Erythromycin Thiocyanate API Price by Type (2019-2024)
5.3.2 Global Erythromycin Thiocyanate API Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Erythromycin Thiocyanate API Sales by Application
6.1.1 Global Erythromycin Thiocyanate API Historical Sales by Application (2019-2024)
6.1.2 Global Erythromycin Thiocyanate API Forecasted Sales by Application (2025-2030)
6.1.3 Global Erythromycin Thiocyanate API Sales Market Share by Application (2019-2030)
6.2 Global Erythromycin Thiocyanate API Revenue by Application
6.2.1 Global Erythromycin Thiocyanate API Historical Revenue by Application (2019-2024)
6.2.2 Global Erythromycin Thiocyanate API Forecasted Revenue by Application (2025-2030)
6.2.3 Global Erythromycin Thiocyanate API Revenue Market Share by Application (2019-2030)
6.3 Global Erythromycin Thiocyanate API Price by Application
6.3.1 Global Erythromycin Thiocyanate API Price by Application (2019-2024)
6.3.2 Global Erythromycin Thiocyanate API Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Erythromycin Thiocyanate API Market Size by Type
7.1.1 US & Canada Erythromycin Thiocyanate API Sales by Type (2019-2030)
7.1.2 US & Canada Erythromycin Thiocyanate API Revenue by Type (2019-2030)
7.2 US & Canada Erythromycin Thiocyanate API Market Size by Application
7.2.1 US & Canada Erythromycin Thiocyanate API Sales by Application (2019-2030)
7.2.2 US & Canada Erythromycin Thiocyanate API Revenue by Application (2019-2030)
7.3 US & Canada Erythromycin Thiocyanate API Market Size by Country
7.3.1 US & Canada Erythromycin Thiocyanate API Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Erythromycin Thiocyanate API Revenue by Country (2019-2030)
7.3.3 US & Canada Erythromycin Thiocyanate API Sales by Country (2019-2030)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Erythromycin Thiocyanate API Market Size by Type
8.1.1 Europe Erythromycin Thiocyanate API Sales by Type (2019-2030)
8.1.2 Europe Erythromycin Thiocyanate API Revenue by Type (2019-2030)
8.2 Europe Erythromycin Thiocyanate API Market Size by Application
8.2.1 Europe Erythromycin Thiocyanate API Sales by Application (2019-2030)
8.2.2 Europe Erythromycin Thiocyanate API Revenue by Application (2019-2030)
8.3 Europe Erythromycin Thiocyanate API Market Size by Country
8.3.1 Europe Erythromycin Thiocyanate API Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Erythromycin Thiocyanate API Sales by Country (2019-2030)
8.3.3 Europe Erythromycin Thiocyanate API Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Erythromycin Thiocyanate API Market Size by Type
9.1.1 China Erythromycin Thiocyanate API Sales by Type (2019-2030)
9.1.2 China Erythromycin Thiocyanate API Revenue by Type (2019-2030)
9.2 China Erythromycin Thiocyanate API Market Size by Application
9.2.1 China Erythromycin Thiocyanate API Sales by Application (2019-2030)
9.2.2 China Erythromycin Thiocyanate API Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Erythromycin Thiocyanate API Market Size by Type
10.1.1 Asia Erythromycin Thiocyanate API Sales by Type (2019-2030)
10.1.2 Asia Erythromycin Thiocyanate API Revenue by Type (2019-2030)
10.2 Asia Erythromycin Thiocyanate API Market Size by Application
10.2.1 Asia Erythromycin Thiocyanate API Sales by Application (2019-2030)
10.2.2 Asia Erythromycin Thiocyanate API Revenue by Application (2019-2030)
10.3 Asia Erythromycin Thiocyanate API Market Size by Region
10.3.1 Asia Erythromycin Thiocyanate API Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Erythromycin Thiocyanate API Revenue by Region (2019-2030)
10.3.3 Asia Erythromycin Thiocyanate API Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Erythromycin Thiocyanate API Market Size by Type
11.1.1 Middle East, Africa and Latin America Erythromycin Thiocyanate API Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Erythromycin Thiocyanate API Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Erythromycin Thiocyanate API Market Size by Application
11.2.1 Middle East, Africa and Latin America Erythromycin Thiocyanate API Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Erythromycin Thiocyanate API Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Erythromycin Thiocyanate API Market Size by Country
11.3.1 Middle East, Africa and Latin America Erythromycin Thiocyanate API Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Erythromycin Thiocyanate API Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Erythromycin Thiocyanate API Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 Yili Chuannig Biotechnology
12.1.1 Yili Chuannig Biotechnology Corporation Information
12.1.2 Yili Chuannig Biotechnology Overview
12.1.3 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Yili Chuannig Biotechnology Recent Developments
12.2 Yichang East Sunshine
12.2.1 Yichang East Sunshine Corporation Information
12.2.2 Yichang East Sunshine Overview
12.2.3 Yichang East Sunshine Erythromycin Thiocyanate API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Yichang East Sunshine Erythromycin Thiocyanate API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Yichang East Sunshine Recent Developments
12.3 Alebi Pharma
12.3.1 Alebi Pharma Corporation Information
12.3.2 Alebi Pharma Overview
12.3.3 Alebi Pharma Erythromycin Thiocyanate API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Alebi Pharma Erythromycin Thiocyanate API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Alebi Pharma Recent Developments
12.4 META Pharmaceuticals
12.4.1 META Pharmaceuticals Corporation Information
12.4.2 META Pharmaceuticals Overview
12.4.3 META Pharmaceuticals Erythromycin Thiocyanate API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 META Pharmaceuticals Erythromycin Thiocyanate API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 META Pharmaceuticals Recent Developments
12.5 Anuh Pharma
12.5.1 Anuh Pharma Corporation Information
12.5.2 Anuh Pharma Overview
12.5.3 Anuh Pharma Erythromycin Thiocyanate API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Anuh Pharma Erythromycin Thiocyanate API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Anuh Pharma Recent Developments
12.6 HEC Group
12.6.1 HEC Group Corporation Information
12.6.2 HEC Group Overview
12.6.3 HEC Group Erythromycin Thiocyanate API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 HEC Group Erythromycin Thiocyanate API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 HEC Group Recent Developments
12.7 AbbVie
12.7.1 AbbVie Corporation Information
12.7.2 AbbVie Overview
12.7.3 AbbVie Erythromycin Thiocyanate API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 AbbVie Erythromycin Thiocyanate API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 AbbVie Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Erythromycin Thiocyanate API Industry Chain Analysis
13.2 Erythromycin Thiocyanate API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Erythromycin Thiocyanate API Production Mode & Process
13.4 Erythromycin Thiocyanate API Sales and Marketing
13.4.1 Erythromycin Thiocyanate API Sales Channels
13.4.2 Erythromycin Thiocyanate API Distributors
13.5 Erythromycin Thiocyanate API Customers
14 Erythromycin Thiocyanate API Market Dynamics
14.1 Erythromycin Thiocyanate API Industry Trends
14.2 Erythromycin Thiocyanate API Market Drivers
14.3 Erythromycin Thiocyanate API Market Challenges
14.4 Erythromycin Thiocyanate API Market Restraints
15 Key Findings in the Global Erythromycin Thiocyanate API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 143
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 95
USD 3950.00
(Single User License)
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 129
USD 2900.00
(Single User License)
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 78
USD 4250.00
(Single User License)
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 95
USD 3950.00
(Single User License)
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-03-10
Pages: 89
USD 2900.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 91
USD 2900.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 108
USD 4350.00
(Single User License)
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 143
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 95
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 129
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 145
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 78
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 95
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 89
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 91
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 108
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now